EXECUTIVE SUMMARY
Due to schedule delays, cost overruns, and several canceled software projects the Chairman of a Fortune 500 company decided to bring in outside experts to identify major software risks and develop solutions for those risks.
Initially the new risk abatement team reported directly to the Chairman, which is unusual but effective. The team visited more than 20 software locations in a dozen countries and met with many software managers and technical personnel. Continue reading
“To do something very dangerous takes a certain lack of imagination”
– Anonymous
INTRODUCTION
Governments and companies worldwide are emerging from the current financial crisis and subsequent recession. While governments are crafting new regulations, businesses around the world are walking in shifting sand as risk exposures are high and new regulations will create compliance challenges. According to a recent survey by Korn/Ferry International, corporate leaders are focusing more attention on risk management after what is considered by many to be excessive risk-taking during the boom times that factored into the global financial crisis. Continue reading
Did we get it all wrong? Wow! This could break our business model. Let me explain:
We developed Certified Enterprise Risk Manager® and all of our risk IP based on a simple fact. We live in VUCA time (volatility, uncertainty, complexity, ambiguity). We based our business business model on providing:
Cyber threats continue to plague governments and businesses around the world. These threats are on the rise as cyber criminals increase their focus and know-how. The problem demands an international solution. ISO/IEC 27001 provides a management framework for assessing and treating risks, whether cyber-oriented or otherwise, that can damage business, governments, and even the fabric of a country’s national infrastructure. Continue reading
In 2002, the Food and Drug Administration (FDA) announced an initiative to integrate quality systems and risk management approaches into existing regulations for pharmaceutical manufacturing. While the FDA hasn’t changed the 21 Code of Federal Regulations (CFR) Parts 210 and/or 211 regulations, they have published industry guidance, Quality Systems Approach to Pharmaceutical CGMP Regulations. Continue reading